BioCentury | Dec 7, 2018
Financial News

Salubris leads Viracta venture round, gets Chinese rights to cancer therapy

...in the round by new investor Virtus Inspire Venture and existing investors NantKwest Inc. (NASDAQ:NK), Latterell Venture Partners...
BioCentury | Dec 4, 2018
Financial News

Salubris leads Viracta venture round, gets Chinese rights to cancer therapy

...in the round by new investor Virtus Inspire Venture and existing investors NantKwest Inc. (NASDAQ:NK), Latterell Venture Partners...
BioCentury | Dec 22, 2017
Financial News

Aptinyx raises $70M series B

...New Leaf Venture Partners, Frazier Healthcare Partners, Longitude Capital, Osage University Partners, Adams Street Partners, LVP...
BioCentury | Dec 22, 2017
Finance

Modulating mechanism

...New Leaf Venture Partners, Frazier Healthcare Partners, Longitude Capital, Osage University Partners, Adams Street Partners, LVP...
BioCentury | Dec 18, 2017
Financial News

Aptinyx raises $70M series B

...New Leaf Venture Partners, Frazier Healthcare Partners, Longitude Capital, Osage University Partners, Adams Street Partners, LVP...
BioCentury | Sep 21, 2017
Tools & Techniques

On your marks

...an undisclosed amount in the first closing of a series B round in April 2017; Latterell Venture Partners...
...HDAC Epstein-Barr virus (EBV)-positive lymphoma Phase I complete $18.4 (A) Forward Ventures; NantKwest Inc. (NASDAQ:NK); Latterell Venture Partners...
BioCentury | Apr 7, 2017
Finance

Combo quest

...Inc. (NASDAQ:NK) took another step toward bolstering its natural killer cell therapy arsenal. Wicklow Capital, Latterell Venture Partners...
BioCentury | Apr 7, 2017
Financial News

Viracta completes venture financing

...B round led by new investor NantKwest Inc. New investor Wicklow Capital and existing investors Latterell Venture Partners...
BioCentury | Apr 4, 2017
Financial News

Viracta raises $18.4M, strikes NantKwest deal

...round led by new investor NantKwest Inc. (NASDAQ:NK). New investor Wicklow Capital and existing investors Latterell Venture Partners...
BioCentury | Jun 27, 2016
Emerging Company Profile

Next-gen NMDA

...Leaf Venture Partners, Frazier Healthcare Partners , Longitude Capital, Osage University Partners, Adams Street Partners, LVP...
Items per page:
1 - 10 of 64
BioCentury | Dec 7, 2018
Financial News

Salubris leads Viracta venture round, gets Chinese rights to cancer therapy

...in the round by new investor Virtus Inspire Venture and existing investors NantKwest Inc. (NASDAQ:NK), Latterell Venture Partners...
BioCentury | Dec 4, 2018
Financial News

Salubris leads Viracta venture round, gets Chinese rights to cancer therapy

...in the round by new investor Virtus Inspire Venture and existing investors NantKwest Inc. (NASDAQ:NK), Latterell Venture Partners...
BioCentury | Dec 22, 2017
Financial News

Aptinyx raises $70M series B

...New Leaf Venture Partners, Frazier Healthcare Partners, Longitude Capital, Osage University Partners, Adams Street Partners, LVP...
BioCentury | Dec 22, 2017
Finance

Modulating mechanism

...New Leaf Venture Partners, Frazier Healthcare Partners, Longitude Capital, Osage University Partners, Adams Street Partners, LVP...
BioCentury | Dec 18, 2017
Financial News

Aptinyx raises $70M series B

...New Leaf Venture Partners, Frazier Healthcare Partners, Longitude Capital, Osage University Partners, Adams Street Partners, LVP...
BioCentury | Sep 21, 2017
Tools & Techniques

On your marks

...an undisclosed amount in the first closing of a series B round in April 2017; Latterell Venture Partners...
...HDAC Epstein-Barr virus (EBV)-positive lymphoma Phase I complete $18.4 (A) Forward Ventures; NantKwest Inc. (NASDAQ:NK); Latterell Venture Partners...
BioCentury | Apr 7, 2017
Finance

Combo quest

...Inc. (NASDAQ:NK) took another step toward bolstering its natural killer cell therapy arsenal. Wicklow Capital, Latterell Venture Partners...
BioCentury | Apr 7, 2017
Financial News

Viracta completes venture financing

...B round led by new investor NantKwest Inc. New investor Wicklow Capital and existing investors Latterell Venture Partners...
BioCentury | Apr 4, 2017
Financial News

Viracta raises $18.4M, strikes NantKwest deal

...round led by new investor NantKwest Inc. (NASDAQ:NK). New investor Wicklow Capital and existing investors Latterell Venture Partners...
BioCentury | Jun 27, 2016
Emerging Company Profile

Next-gen NMDA

...Leaf Venture Partners, Frazier Healthcare Partners , Longitude Capital, Osage University Partners, Adams Street Partners, LVP...
Items per page:
1 - 10 of 64